Development Center for Biotechnology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Development Center for Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9307
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Development Center for Biotechnology (DCB) is a non profit organization that offers support to biotechnology and pharmaceutical companies. The organization develops biotech industry through its cooperation and industrialization, key technologies, infrastructure building, research and development, and training programs to workforce. It provides preclinical development services in the areas of medicinal chemistry and lead optimization to pharmacology and safety studies, among others. DCB offers testing facility for biological safety, CGMP bio-pharmaceutical pilot plant facilities, research technology and industrial promotion services, among others. The organization operates through government, research institutes, academic institutions, life science industry, and others. It operates through its two offices in Taipei, Taiwan. DCB is headquartered in Taipei City, Taiwan.

Development Center for Biotechnology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Development Center for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
UBI Pharma Enters into Licensing Agreement with Development Center for Biotechnology 10
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Advagene Biopharma Enters into Technology Transfer Agreement with Development Center for Biotechnology 12
DCB Enters Into Licensing Agreement With JoBen Bio-Medical To Develop Anti-Cancer Drugs 13
Asset Transactions 14
EirGenix Acquires Biopharmaceutical Pilot Production Facility From Development Center For Biotechnology 14
Development Center for Biotechnology – Key Competitors 15
Development Center for Biotechnology – Key Employees 16
Development Center for Biotechnology – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Key Facts 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Development Center for Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Development Center for Biotechnology, Deals By Therapy Area, 2012 to YTD 2018 8
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
UBI Pharma Enters into Licensing Agreement with Development Center for Biotechnology 10
HuniLife Biotech Enters into Licensing Agreement with DCB and NHRI 11
Advagene Biopharma Enters into Technology Transfer Agreement with Development Center for Biotechnology 12
DCB Enters Into Licensing Agreement With JoBen Bio-Medical To Develop Anti-Cancer Drugs 13
EirGenix Acquires Biopharmaceutical Pilot Production Facility From Development Center For Biotechnology 14
Development Center for Biotechnology, Key Competitors 15
Development Center for Biotechnology, Key Employees 16
Development Center for Biotechnology, Other Locations 17

List of Figures
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Development Center for Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Development Center for Biotechnology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teva Pharmaceuticals USA Inc:企業のM&A・事業提携・投資動向
    Teva Pharmaceuticals USA Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teva Pharmaceuticals USA Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Meredith Corporation:企業の戦略・SWOT・財務情報
    Meredith Corporation - Strategy, SWOT and Corporate Finance Report Summary Meredith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • mBio Diagnostics Inc:医療機器:M&Aディール及び事業提携情報
    Summary MBio Diagnostics Inc (MBio) is a medical device company that offers clinical diagnostics and sample testing solutions. The company offers MBio multiplex analyzer and disposable cartridges. Its MBio Array System is a fluorescence immunoassay system that provides measurement of analytes from a …
  • Fluidigm Corp (FLDM):医療機器:M&Aディール及び事業提携情報
    Summary Fluidigm Corp (Fluidigm), formerly Mycometrix Corp, develops, manufactures, and markets life science analytical and preparatory systems for mass cytometry, high-throughput genomics, and single-cell genomics markets. The company offers analytical systems and instruments, preparatory instrumen …
  • Porton Fine Chemicals Ltd (300363):製薬・医療:M&Aディール及び事業提携情報
    Summary Porton Fine Chemicals Ltd (Porton) is a supplier of custom drug intermediates and active pharmaceutical ingredients. The company provides custom and contract chemical development, and contract manufacturing services. It provides products such as reactive reagents, chiral chromatography produ …
  • Walchandnagar Industries Ltd
    Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Walchandnagar Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Bharti Infratel Ltd:企業の戦略・SWOT・財務分析
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Sumitomo Corporation:企業の戦略・SWOT・財務分析
    Sumitomo Corporation - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Keyence Corp (6861):企業の財務・戦略的SWOT分析
    Keyence Corp (6861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Yokohama Rubber Co., Ltd.:企業の戦略・SWOT・財務情報
    The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Yokohama Rubber Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Axel Springer SE:企業の戦略・SWOT・財務情報
    Axel Springer SE - Strategy, SWOT and Corporate Finance Report Summary Axel Springer SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Generali Brasil Seguros S.A.:企業の戦略・SWOT・財務情報
    Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Generali Brasil Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Can-One Berhad:企業の戦略・SWOT・財務情報
    Can-One Berhad - Strategy, SWOT and Corporate Finance Report Summary Can-One Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TG Therapeutics Inc (TGTX):企業の財務・戦略的SWOT分析
    TG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Regulus Therapeutics Inc (RGLS):企業の財務・戦略的SWOT分析
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • DLF Limited:企業の戦略・SWOT・財務情報
    DLF Limited - Strategy, SWOT and Corporate Finance Report Summary DLF Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Deutsche Borse AG:企業の戦略・SWOT・財務情報
    Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Kallpa Generacion SA:企業の戦略的SWOT分析
    Kallpa Generacion SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Valvoline Inc (VVV):企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆